Dutch OTC Market in 2019: VMS Delisting Accelerates Shift Towards Self-Care
Executive Summary
A delisting of vitamin D and calcium food supplements accelerates a long-term shift towards self-care among Dutch consumers, according to the latest market data from local industry association, Neprofarm, in collaboration with IQVIA.
You may also be interested in...
Dutch Parliament To Decide Future Of OTC Market
In January, the Dutch Parliament will debate an amendment to the country's medicines legislation that proposes to remove the requirement for a druggist or assistant druggist to be physically present during the sale of self-care medicines. The move will once again allow supermarkets to sell UAD medicines, with the help of digital tablets offering professional advice, hastening the transformation of the Dutch OTC market, according to Neprofarm's Bernard Mauritz.
COVID VMS Boom Driving Shift To Self-Care As The Netherlands Bucks 2020 Sales Trends
Despite the pandemic, the Dutch OTC market recorded impressive growth of 4.6% in 2020. HBW Insight speaks to Bernard Mauritz, director of the Netherlands' self-care industry association, Neprofarm, about how the country bucked negative sales trends seen in other European OTC markets.
The Dutch OTC Market In 2018: Pharmacists Not Consumer Friendly, Supermarkets Capitalize
While the Dutch OTC market grew steadily by 3.2% to €753m in 2018, according to IQVIA data, the country's self-care industry association, Neprofarm, pointed to a changing retail landscape in the Netherlands where supermarkets are grabbing market share from pharmacies.